Cambridge biotech Alkeus Pharmaceuticals raises $150 million, rehires Vertex founder

Alkeus Pharmaceuticals has been buoyed by clinical trial results for its experimental drug to treat Stargardt disease, a rare inherited cause of blindness.

Related Keywords

United States ,Wellington ,New Zealand General ,New Zealand ,Boston ,Massachusetts ,Joshua Boger ,Leonide Saad ,Bain Capital Life Sciences ,Columbia University Medical Center ,Drug Administration ,Vertex Pharmaceuticals ,Columbia University ,Alkeus Pharmaceuticals ,Ilyas Washington ,Columbia University Medical ,Wellington Management , ,